BCI

We are deeply passionate about helping these patient populations with debilitating disease states and no other options (Quadriplegia, ALS, SCI, Stroke, etc). We recently submitted public comments to the US FDA to help steer their public policy on Benefit-Risk and Benefit-Impairment relationships.

‍

https://downloads.regulations.gov/FDA-2024-N-2976-0004/attachment_1.pdf